We are live on ! Find out more
NAP

New Amsterdam Partners Portfolio holdings

AUM $272M
1-Year Est. Return 12.21%
This Fund
S&P 500
This Quarter Est. Return
-0.89%
1 Year Est. Return
+12.21%
3 Year Est. Return
+73.94%
5 Year Est. Return
+120.95%
10 Year Est. Return
AUM
$458M
AUM Growth
-$42.3M
Cap. Flow
-$29.1M
Cap. Flow %
-6.35%
Top 10 Hldgs %
25.63%
Holding
140
New
27
Increased
15
Reduced
71
Closed
27

Top Buys

Rank Stock Value
1
AMN icon
AMN Healthcare
AMN
+$6.02M
2
FHI icon
Federated Hermes
FHI
+$5.71M
3
EXLS icon
EXL Service
EXLS
+$5.54M
4
MKSI icon
MKS Inc
MKSI
+$5.54M
5
USCR
U S Concrete, Inc.
USCR
+$3.66M

Sector Composition

Rank Sector Weight
1 Technology 19.22%
2 Industrials 19.04%
3 Consumer Discretionary 15.72%
4 Financials 13.25%
5 Healthcare 10.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMHC
26
DELISTED
Taylor Morrison
TMHC
$6.51M 1.42%
279,671
-10,033
-3% -$250K
AMN icon
27
AMN Healthcare
AMN
$1.34B
$6.29M 1.37%
+110,820
New +$6.02M
PATK icon
28
Patrick Industries
PATK
$2.68B
$6.16M 1.34%
149,312
-64,122
-30% -$2.77M
CNS icon
29
Cohen & Steers
CNS
$4.25B
$6.13M 1.34%
150,705
-6,046
-4% -$254K
NSP icon
30
Insperity
NSP
$2.04B
$6.07M 1.33%
87,241
-3,323
-4% -$212K
MKSI icon
31
MKS Inc
MKSI
$17.3B
$5.83M 1.27%
+50,435
New +$5.54M
IPGP icon
32
IPG Photonics
IPGP
$3.26B
$5.82M 1.27%
24,952
-6,153
-20% -$1.52M
ARW icon
33
Arrow Electronics
ARW
$10.4B
$5.79M 1.26%
75,129
+2,166
+3% +$176K
SYKE
34
DELISTED
SYKES Enterprises Inc
SYKE
$5.77M 1.26%
199,527
-8,091
-4% -$246K
NVR icon
35
NVR
NVR
$17B
$5.75M 1.26%
2,054
-151
-7% -$480K
KNL
36
DELISTED
Knoll, Inc.
KNL
$5.64M 1.23%
279,133
-10,709
-4% -$237K
FHI icon
37
Federated Hermes
FHI
$4.81B
$5.61M 1.23%
+167,953
New +$5.71M
AMG icon
38
Affiliated Managers Group
AMG
$9.59B
$5.28M 1.15%
27,869
-1,911
-6% -$372K
EXLS icon
39
EXL Service
EXLS
$5.82B
$5.18M 1.13%
+464,655
New +$5.54M
NSIT icon
40
Insight Enterprises
NSIT
$4.57B
$4.95M 1.08%
141,565
-3,818
-3% -$138K
KLXI
41
DELISTED
KLX Inc.
KLXI
$4.93M 1.08%
82,340
-5,687
-6% -$332K
IDCC icon
42
InterDigital
IDCC
$8.65B
$4.58M 1%
62,295
-2,463
-4% -$189K
CPK icon
43
Chesapeake Utilities
CPK
$3.2B
$4.32M 0.94%
61,410
-1,413
-2% -$101K
LII icon
44
Lennox International
LII
$13.6B
$3.76M 0.82%
18,394
-1,249
-6% -$260K
ALGN icon
45
Align Technology
ALGN
$11.2B
$3.58M 0.78%
14,249
-4,856
-25% -$1.25M
SIVB
46
DELISTED
SVB Financial Group
SIVB
$3.55M 0.78%
14,799
-1,346
-8% -$338K
CRUS icon
47
Cirrus Logic
CRUS
$5.44B
$3.47M 0.76%
85,470
-85,077
-50% -$3.95M
GMED icon
48
Globus Medical
GMED
$11.1B
$3.47M 0.76%
69,601
-83,305
-54% -$3.92M
CAKE icon
49
Cheesecake Factory
CAKE
$5.58B
$3.4M 0.74%
+70,503
New +$3.39M
AGX icon
50
Argan
AGX
$5.86B
$3.38M 0.74%
78,707
-2,647
-3% -$111K

Similar funds

New Amsterdam Partners's Q1 2018 Portfolio in Review

As of Q1 2018, New Amsterdam Partners held 140 positions worth $458M, down 8.5% from $500M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

New Amsterdam Partners withdrew a net $29.1M in Q1 2018, closing 27 positions and reducing 71 holdings. Its most notable exit was Innospec, an estimated $12.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, New Amsterdam Partners opened a new position in AMN Healthcare worth $6.29M.

  • New Amsterdam Partners's largest Q1 2018 buy was AMN Healthcare: 110,820 shares worth $6.29M.
  • New Amsterdam Partners added most to Regal Rexnord in Q1 2018, an estimated $3.49M increase.
  • New Amsterdam Partners's biggest Q1 2018 reduction was NutriSystem, Inc., cutting an estimated $4.33M.
  • New Amsterdam Partners fully exited Innospec in Q1 2018, selling an estimated $12.6M.
  • New Amsterdam Partners's ten largest holdings make up 26% of its $458M portfolio in Q1 2018.
  • New Amsterdam Partners opened 27 new positions and closed 27 in Q1 2018.
  • New Amsterdam Partners's portfolio value fell 8.5% quarter-over-quarter to $458M.

Based on New Amsterdam Partners's 13F filing for Q1 2018, filed 7 May 2018.